Seminars in Hematology
Volume 42, Issue 1 , Pages 56-62 , January 2005

Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies

  • Kenji Soejima

      Affiliations

    • First Research Department, The Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan
    • Corresponding Author InformationAddress correspondence to Kenji Soejima, PhD, First Research Department, The Chemo-Sero-Therapeutic Research Institute, Kawabe, Kyokushi, Kikuchi, Kumamoto 869-1298, Japan
    • ,
  • Tomohiro Nakagaki

      Affiliations

    • First Research Department, The Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan

References 

  1. Moake JL . Thrombotic microangiopathies . N Engl J Med . 2002;347:589–600
  2. Moschcowitz E . Hyalin thrombosis of the terminal arterioles and capillaries (A hitherto undescribed disease) . Proc N Y Pathol Soc . 1924;24:21–24
  3. Gasser C , Gautier E , Steck A , Siebenmann RE , Oechslin R . Hämolytisch-urämische Syndrome (bilaterale Nierenrindennekrosen bei akuten erworbenen hämolytischen Anämien) . Schweiz Med Wochenschr . 1955;85:905–909
  4. Moake JL , Rudy CK , Troll JH , Weinstein MJ , Colannino NM , Azocar J , et al.   Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura . N Engl J Med . 1982;307:1432–1435
  5. Furlan M , Robles R , Lämmle B . Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis . Blood . 1996;87:4223–4234
  6. Tsai H-M . Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion . Blood . 1996;87:4235–4244
  7. Furlan M , Robles R , Solenthaler M , Wassmer M , Sandoz P , Lämmle B . Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura . Blood . 1997;89:3097–3103
  8. Furlan M , Robles R , Galbusera M , Remuzzi G , Kyrle PA , Brenner B , et al.   von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome . N Engl J Med . 1998;339:1578–1584
  9. Furlan M , Robles R , Solenthaler M , Lämmle B . Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura . Blood . 1998;91:2839–2846
  10. Tsai H-M , Lian EC . Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura . N Engl J Med . 1998;339:1585–1594
  11. Matsumoto M , Yagi H , Ishizashi H , Wada H , Fujimura Y . The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome . Semin Hematol . 2004;41:68–74
  12. Furlan M . Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura . Expert Rev Cardiovasc Ther . 2003;1:243–255
  13. George JN , Sadler JE , Lämmle B . Platelets (Thrombotic thrombocytopenic purpura) . Hematology (Am Soc Hematol Educ Program) . 2002;9:315–334
  14. Kinoshita S , Yoshioka A , Park YD , Ishizashi H , Konno M , Funato M , et al.   Upshaw-Schulman syndrome revisited (A concept of congenital thrombotic thrombocytopenic purpura) . Int J Hematol . 2001;74:101–108
  15. Richards A , Goodship JA , Goodship TH . The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura . Curr Opin Nephrol Hypertens . 2002;11:431–435
  16. Zipfel PF , Neumann HP , Jozsi M . Genetic screening in haemolytic uraemic syndrome . Curr Opin Nephrol Hypertens . 2003;12:653–657
  17. McLeod BC . Thrombotic microangiopathies in bone marrow and organ transplant patients . J Clin Apheresis . 2002;17:118–123
  18. George JN . The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome . Curr Opin Hematol . 2003;10:339–344
  19. Chiurchiu C , Ruggenenti P , Remuzzi G . Thrombotic microangiopathy in renal transplantation . Ann Transplant . 2002;7:28–33
  20. Kokame K , Matsumoto M , Fujimura Y , Miyata T . VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13 . Blood . 2004;103:607–612
  21. Whitelock JL , Nolasco L , Bernardo A , Moake J , Dong JF , Cruz MA . ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate . J Thromb Haemost . 2004;2:485–491
  22. Zhou W , Tsai HM . An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations . Thromb Haemost . 2004;91:806–811
  23. Scheiflinger F , Knobl P , Trattner B , Plaimauer B , Mohr G , Dockal M , et al.   Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura . Blood . 2003;102:3241–3243
  24. Zheng XL , Kaufman RM , Goodnough LT , Sadler JE . Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura . Blood . 2004;103:4043–4049
  25. Zimmerman TS , Ratnoff OD , Powell AE . Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand’s disease, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor . J Clin Invest . 1971;50:244–254
  26. Zimmerman TS , Ruggeri ZM . von Willebrand disease . Hum Pathol . 1987;18:140–152
  27. Sadler JE . Biochemistry and genetics of von Willebrand factor . Annu Rev Biochem . 1998;67:395–424
  28. Ruggeri ZM . Von Willebrand factor, platelets and endothelial cell interactions . J Thromb Haemost . 2003;1:1335–1342
  29. Jaffe EA , Hoyer LW , Nachman RL . Synthesis of von Willebrand factor by cultured human endothelial cells . Proc Natl Acad Sci U S A . 1974;71:1906–1909
  30. Nachman R , Levine R , Jaffe EA . Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes . J Clin Invest . 1977;60:914–921
  31. Sixma JJ , Sakariassen KS , Beeser-Visser NH , Ottenhof-Rovers M , Bolhuis PA . Adhesion of platelets to human artery subendothelium (Effect of factor VIII-von Willebrand factor of various multimeric composition) . Blood . 1984;63:128–139
  32. Sporn LA , Marder VJ , Wagner DD . Inducible secretion of large, biologically potent von Willebrand factor multimers . Cell . 1986;46:185–190
  33. Sporn LA , Marder VJ , Wagner DD . von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively . Blood . 1987;69:1531–1534
  34. Siedlecki CA , Lestini BJ , Kottke-Marchant KK , Eppell SJ , Wilson DL , Marchant RE . Shear-dependent changes in the three-dimensional structure of human von Willebrand factor . Blood . 1996;88:2939–2950
  35. Kuwahara M , Sugimoto M , Tsuji S , Matsui H , Mizuno T , Miyata S , et al.   Platelet shape changes and adhesion under high shear flow . Arterioscler Thromb Vasc Biol . 2002;22:329–334
  36. Dent JA , Berkowitz SD , Ware J , Kasper CK , Ruggeri ZM . Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor . Proc Natl Acad Sci U S A . 1990;87:6306–6310
  37. Borchiellini A , Fijnvandraat K , ten Cate JW , Pajkrt D , van Deventer SJ , Pasterkamp G , et al.   Quantitative analysis of von Willebrand factor propeptide release in vivo (Effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans) . Blood . 1996;88:2951–2958
  38. Gerritsen HE , Robles R , Lämmle B , Furlan M . Partial amino acid sequence of purified von Willebrand factor-cleaving protease . Blood . 2001;98:1654–1661
  39. Fujikawa K , Suzuki H , McMullen B , Chung D . Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family . Blood . 2001;98:1662–1666
  40. Soejima K , Mimura N , Hirashima M , Maeda H , Hamamoto T , Nakagaki T , et al.   A novel human metalloprotease synthesized in the liver and secreted into the blood (Possibly, the von Willebrand factor-cleaving protease?) . J Biochem . 2001;130:475–480
  41. Zheng X , Chung D , Takayama TK , Majerus EM , Sadler JE , Fujikawa K . Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura . J Biol Chem . 2001;276:41059–41063
  42. Kuno K , Kanada N , Nakashima E , Fujiki F , Ichimura F , Matsushima K . Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene . J Biol Chem . 1997;272:556–562
  43. Tang BL . ADAMTS (A novel family of extracellular matrix proteases) . Int J Biochem Cell Biol . 2001;33:33–44
  44. Levy GG , Nichols WC , Lian EC , et al.   Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura . Nature . 2001;413:488–494
  45. Bork P , Beckmann G . The CUB domain. A widespread module in developmentally regulated proteins . J Mol Biol . 1993;231:539–545
  46. Ruoslahti E , Pierschbacher MD . Arg-Gly-Asp (A versatile cell recognition signal) . Cell . 1986;44:517–518
  47. Chung DW , Fujikawa K . Processing of von Willebrand factor by ADAMTS-13 . Biochemistry . 2002;41:11065–11070
  48. Zheng X , Majerus EM , Sadler JE . ADAMTS13 and TTP . Curr Opin Hematol . 2002;9:389–394
  49. Cal S , Obaya AJ , Llamazares M , Garabaya C , Quesada V , Lopez-Otin C . Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains . Gene . 2002;283:49–62
  50. Kokame K , Matsumoto M , Soejima K , Yagi H , Ishizashi H , Funato M , et al.   Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity . Proc Natl Acad Sci U S A . 2002;99:11902–11907
  51. Plaimauer B , Zimmermann K , Volkel D , Antoine G , Kerschbaumer R , Jenab P , et al.   Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13) . Blood . 2002;100:3626–3632
  52. Zheng X , Nishio K , Majerus EM , Sadler JE . Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13 . J Biol Chem . 2003;278:30136–30141
  53. Furlan M , Robles R , Morselli B , Sandoz P , Lämmle B . Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura . Thromb Haemost . 1999;81:8–13
  54. Soejima K , Matsumoto M , Kokame K , Yagi H , Ishizashi H , Maeda H , et al.   ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage . Blood . 2003;102:3232–3237
  55. Banno F , Kaminaka K , Soejima K , Kokame K , Miyata T . Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease . J Biol Chem . 2004;279:30896–30903
  56. Majerus EM , Zheng X , Tuley EA , Sadler JE . Cleavage of the ADAMTS13 propeptide is not required for protease activity . J Biol Chem . 2003;278:46643–46648
  57. Suzuki M , Murata M , Matsubara Y , Uchida T , Ishihara H , Shibano T , et al.   Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets . Biochem Biophys Res Commun . 2004;313:212–216
  58. Schneppenheim R , Budde U , Oyen F , Angerhaus D , Aumann V , Drewke E , et al.   von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP . Blood . 2003;101:1845–1850
  59. Antoine G , Zimmermann K , Plaimauer B , Grillowitzer M , Studt JD , Lämmle B , et al.   ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13 . Br J Haematol . 2003;120:821–824
  60. Assink K , Schiphorst R , Allford S , Karpman D , Etzioni A , Brichard B , et al.   Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency . Kidney Int . 2003;63:1995–1999
  61. Savasan S , Lee SK , Ginsburg D , Tsai HM . ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity . Blood . 2003;101:4449–4451
  62. Matsumoto M , Kokame K , Soejima K , Miura M , Hayashi S , Fujii Y , et al.   Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome . Blood . 2004;103:1305–1310
  63. Schneppenheim R , Budde U , Hassenpflug W , Obser T . Severe ADAMTS-13 deficiency in childhood . Semin Hematol . 2004;41:83–89
  64. Pimanda JE , Maekawa A , Wind T , Paxton J , Chesterman CN , Hogg PJ . Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13 . Blood . 2004;103:627–629
  65. Veyradier A , Lavergne JM , Ribba AS , Obert B , Loirat C , Meyer D , et al.   Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) . J Thromb Haemost . 2004;2:424–429
  66. Uchida T , Wada H , Mizutani M , Iwashita M , Ishihara H , Shibano T , et al.   Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura . Blood . 2004;104:2081–2083
  67. Klaus C , Plaimauer B , Studt JD , Dorner F , Lämmle B , Mannucci PM , et al.   Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura . Blood . 2004;103:4514–4519
  68. Dong JF , Moake JL , Bernardo A , Fujikawa K , Ball C , Nolasco L , et al.   ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor . J Biol Chem . 2003;278:29633–29639
  69. Dong JF , Moake JL , Nolasco L , Bernardo A , Arceneaux W , Shrimpton CN , et al.   ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions . Blood . 2002;100:4033–4039
  70. Padilla A , Moake JL , Bernardo A , Ball C , Wang Y , Arya M , et al.   P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface . Blood . 2004;103:2150–2156
  71. Datta YH , Ewenstein BM . Regulated secretion in endothelial cells (Biology and clinical implications) . Thromb Haemost . 2001;86:1148–1155
  72. Mannucci PM , Canciani MT , Forza I , Lussana F , Lattuada A , Rossi E . Changes in health and disease of the metalloprotease that cleaves von Willebrand factor . Blood . 2001;98:2730–2735
  73. Reiter RA , Knobl P , Varadi K , Turecek PL . Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin . Blood . 2003;101:946–948
  74. Moore JC , Hayward CP , Warkentin TE , Kelton JG . Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders . Blood . 2001;98:1842–1846
  75. Bianchi V , Robles R , Alberio L , Furlan M , Lämmle B . Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders (A severely deficient activity is specific for thrombotic thrombocytopenic purpura) . Blood . 2002;100:710–713
  76. Tsai HM . Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura . J Am Soc Nephrol . 2003;14:1072–1081
  77. Nishio K , Anderson PJ , Zheng XL , Sadler JE . Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13 . Proc Natl Acad Sci U S A . 2004;101:10578–10583
  78. Crawley JT, Lam JK, Rance JB, Mollica LR, O’Donnell JS, Lane DA: Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood (in press)
  79. Xie L , Chesterman CN , Hogg PJ . Control of von Willebrand factor multimer size by thrombospondin-1 . J Exp Med . 2001;193:1341–1349
  80. Pimanda JE , Ganderton T , Maekawa A , Yap CL , Lawler J , Kershaw G , et al.   Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice . J Biol Chem . 2004;279:21439–21448

PII: S0037-1963(04)00213-6

doi: 10.1053/j.seminhematol.2004.09.008

Seminars in Hematology
Volume 42, Issue 1 , Pages 56-62 , January 2005

Article Tools

* Image Usage & Resolution